Показано 0 из 0
Дата |
---|
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.34
|
5.54
|
5.29
|
5.29
|
5.45
|
5.45
|
|
|
30 833.45
|
38.00
|
5.13
|
5.49
|
5.25
|
5.22
|
5.36
|
5.22
|
|
|
9 715.56
|
23.00
|
5.14
|
5.40
|
5.11
|
5.11
|
5.20
|
5.195
|
|
|
4 726.01
|
27.00
|
4.97
|
5.47
|
5.25
|
5.24
|
5.31
|
5.24
|
|
|
5 173.25
|
32.00
|
5.07
|
5.27
|
5.33
|
5.15
|
5.33
|
5.28
|
|
|
19 750.20
|
57.00
|
5.11
|
5.35
|
5.17
|
5.17
|
5.27
|
5.27
|
|
|
5 850.07
|
31.00
|
5.11
|
5.23
|
5.28
|
5.00
|
5.38
|
5.23
|
|
|
17 011.18
|
50.00
|
5.01
|
5.29
|
5.40
|
5.21
|
5.40
|
5.21
|
|
|
16 209.72
|
32.00
|
5.28
|
5.58
|
5.43
|
5.42
|
5.49
|
5.49
|
|
|
38 286.53
|
59.00
|
5.31
|
5.80
|
5.27
|
5.11
|
5.425
|
5.425
|
|
|
18 719.48
|
101.00
|
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany.